Purple Biotech (PPBT) EPS (Diluted) (2021 - 2026)
Purple Biotech (PPBT) posted EPS (Diluted) of -$0.92 for Q2 2026, compared with $6.62 a year earlier.
Powered by 
Analysis
Purple Biotech (PPBT) EPS (Diluted) (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EPS (Diluted) at Purple Biotech was $51.02, up 220.4% year-over-year; for FY2025, it came in at $55.19, up 24.3% from FY2024.
- Annual EPS (Diluted) shows a five-year compound annual growth rate of -35.3% (FY2020 to FY2025).
- In prior years, Purple Biotech's EPS (Diluted) was $44.39 in FY2024 (-75.4%), $180.52 in FY2023 (-25.0%), $240.69 in FY2022 (+14.5%) and $210.25 in FY2021 (-56.9%).
- The Q2 2026 figure stands as the lowest quarterly EPS (Diluted) in data going back to Q1 2021.
- On a year-over-year basis, EPS (Diluted) increased in 1 of the last six quarters, with an average decline of 67.6%.
- The strongest year-over-year quarter for EPS (Diluted) in the past five years was Q2 2023, with growth of 41.2%; the weakest was Q4 2024, with a decline of 94.3%.
- According to Business Quant data, EPS (Diluted) for the three prior quarters was $0.18 (Q1 2026), $49.05 (Q4 2025) and $7.95 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 4.31 |
| 10 | Purple Biotech | 249,214.64 | 191,214.64 | - | -0.92 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.92 |
| Mar 31, 2026 | 0.18 |
| Dec 31, 2025 | 49.05 |
| Sep 30, 2025 | 7.95 |
| Jun 30, 2025 | 6.62 |
| Mar 31, 2025 | 2.76 |
| Dec 31, 2024 | 2.50 |
| Sep 30, 2024 | 5.99 |
| Jun 30, 2024 | 21.73 |
| Mar 31, 2024 | 33.99 |
| Dec 31, 2023 | 43.63 |
| Sep 30, 2023 | 55.70 |
| Jun 30, 2023 | 56.83 |
| Mar 31, 2023 | 53.96 |
| Dec 31, 2022 | 66.49 |
| Sep 30, 2022 | 54.92 |
| Jun 30, 2022 | 40.26 |
| Mar 31, 2022 | 83.07 |
| Dec 31, 2021 | 58.13 |
| Sep 30, 2021 | 54.76 |
API Access
Purple Biotech EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=PPBT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "PPBT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=PPBT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();